APA (7th ed.) Citation

Sato, N., Shimodaira, S., Saruta, M., Shimizu, Y., Koido, S., Taguchi, J., . . . Ito, M. (2025). Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms’ tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Sato, Nobuhiro, et al. Predictors of Patients with Advanced Pancreatic Cancer Undergoing Conversion Surgery via Chemoimmunotherapy with a Multifunctional Wilms’ Tumor 1 (WT1) Peptide Cocktail-pulsed Dendritic Cell Vaccine. BMJ Publishing Group, 2025.

MLA (9th ed.) Citation

Sato, Nobuhiro, et al. Predictors of Patients with Advanced Pancreatic Cancer Undergoing Conversion Surgery via Chemoimmunotherapy with a Multifunctional Wilms’ Tumor 1 (WT1) Peptide Cocktail-pulsed Dendritic Cell Vaccine. BMJ Publishing Group, 2025.